A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study
Evaluating the Safety and Efficacy of Efruxifermin in Subjects with
Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)
Please contact us for more information or to learn if you are eligible to participate.
